Alzheimer's patients with a baseline CDR-SB score of 3.5 could expect approximately 4 additional months (95% CI 2-7 months) ...

A study reveals how a common gut bacterium may accelerate Alzheimer’s disease, reshaping medical perspectives on brain health ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...

Alzheimer's disease (AD), the most common form of dementia, continues to remain one of modern medicine's greatest challenges.

Research finds that 40 percent of dementia cases may be preventable—and healthy diets rich in polyphenols, healthy fats, and ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...

Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily ...

Scientists restore a key Alzheimer’s pathway, revealing a potential new treatment by targeting harmful oxysterol buildup.

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving early Alzheimer’s diagnosis. Unlike amyloid-beta, tau neurofibrillary ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.

Researchers combined animal models, human brain tissue, and molecular analysis to uncover a connection between Alzheimer's ...